股票/基金 实时行情 股吧

简称:恒瑞医药 代码:600276


会计年度:2011-12-31收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
其他业务收入55,766,403.0050,862,256.004,904,147.008.79

会计年度:2011-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
片剂药454,159,290.00104,042,033.00350,117,257.4677.09
其他32,043,587.0030,277,525.001,766,062.185.51
原料药24,303,948.0019,739,846.004,564,101.6618.78
针剂药1,647,427,767.00200,372,326.001,447,055,441.2887.84

会计年度:2010-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
医药制造业3,666,937,292.53533,387,418.33----
医药商业60,791,680.7757,253,795.36----
合计3,727,728,973.30590,641,213.69----
片剂697,913,524.29120,343,732.27577,569,792.02--
其他60,791,680.7757,253,795.363,537,885.41--
原料药51,088,588.8533,000,269.8418,088,319.01--
针剂2,917,935,179.39380,043,416.222,537,891,763.17--

会计年度:2010-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
片剂药362,723,151.0058,837,307.00303,885,844.2883.78
其他28,509,325.3127,025,091.351,484,233.965.21
原料药26,938,398.0015,862,872.0011,075,525.3541.11
针剂药1,448,146,779.00179,548,845.001,268,597,934.1887.60

会计年度:2009-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
片剂药556,991,257.5895,608,713.79----
其他56,297,041.6752,661,483.31----
原料药41,800,891.1525,545,523.16----
针剂药2,366,117,577.38344,551,737.43----

    4/8 转到